Astrazeneca

FromAstraZeneca ([email protected])
Subject (39)Evusheld approved for COVID-19 in Japan
Preheader (100)Evusheld long-acting antibody combination approved for prevention and treatment of COVID-19 in Japan
Typography
Arial
Colors
Text Analysis
Body Words210
Subject Words6
Body Emojis1
Subject Emojis
Media Analysis
Text Links8
Image Links4
Total Links12
Images7
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px744 px
X-Spam Score-0.1
Preheader OptimizedNo
Timing
Day of WeekWednesday
TimeOvernight

Evusheld approved for COVID-19 in Japan

Evusheld long-acting antibody combination approved for prevention and treatment of COVID-19 in Japan
Evusheld approved for COVID-19 in Japan